Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.560
-0.030 (-1.89%)
At close: Nov 7, 2025, 4:00 PM EST
1.530
-0.030 (-1.90%)
After-hours: Nov 7, 2025, 4:55 PM EST
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $83.79 million as of November 7, 2025. Its market cap has increased by 122.56% in one year.
Market Cap
83.79M
Enterprise Value
66.57M
1-Year Change
122.56%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $83.79M, a decrease of -90.21%. That is a compound annual growth rate of -30.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 83.79M | 1.84% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | 819.45M | -45.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 852.66B |
| Johnson & Johnson | 449.36B |
| AbbVie | 380.59B |
| UnitedHealth Group | 296.66B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 216.19B |
| Novo Nordisk | 215.64B |